Synthetic Biology Approaches to Biological Containment: Pre-Emptively Tackling Potential Risks
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Addressing Evolutionary Questions with Synthetic Biology
Addressing evolutionary questions with synthetic biology Florian Baier and Yolanda Schaerli Department of Fundamental Microbiology, University of Lausanne, Biophore Building, 1015 Lausanne, Switzerland Correspondence: [email protected]; [email protected] Abstract Synthetic biology emerged as an engineering discipline to design and construct artificial biological systems. Synthetic biological designs aim to achieve specific biological behavior, which can be exploited for biotechnological, medical and industrial purposes. In addition, mimicking natural systems using well-characterized biological parts also provides powerful experimental systems to study evolution at the molecular and systems level. A strength of synthetic biology is to go beyond nature’s toolkit, to test alternative versions and to study a particular biological system and its phenotype in isolation and in a quantitative manner. Here, we review recent work that implemented synthetic systems, ranging from simple regulatory circuits, rewired cellular networks to artificial genomes and viruses, to study fundamental evolutionary concepts. In particular, engineering, perturbing or subjecting these synthetic systems to experimental laboratory evolution provides a mechanistic understanding on important evolutionary questions, such as: Why did particular regulatory networks topologies evolve and not others? What happens if we rewire regulatory networks? Could an expanded genetic code provide an evolutionary advantage? How important is the structure of genome and number of chromosomes? Although the field of evolutionary synthetic biology is still in its teens, further advances in synthetic biology provide exciting technologies and novel systems that promise to yield fundamental insights into evolutionary principles in the near future. 1 1. Introduction Evolutionary biology traditionally studies past or present organisms to reconstruct past evolutionary events with the aim to explain and predict their evolution. -
(12) Patent Application Publication (10) Pub. No.: US 2013/0203610 A1 Meller Et Al
US 20130203610A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0203610 A1 Meller et al. (43) Pub. Date: Aug. 8, 2013 (54) TOOLS AND METHOD FOR NANOPORES Related U.S. Application Data UNZIPPING-DEPENDENT NUCLECACID (60) Provisional application No. 61/318,872, filed on Mar. SEQUENCING 30, 2010. (75) Inventors: Amit Meller, Brookline, MA (US); Alon Publication Classification Singer, Brighton, MA (US) (51) Int. Cl. (73) Assignee: TRUSTEES OF BOSTON CI2O I/68 (2006.01) UNIVERSITY, Boston, MA (US) (52) U.S. Cl. CPC .................................... CI2O I/6874 (2013.01) (21) Appl. No.: 13/638,455 USPC ................................................. 506/6:506/16 (57) ABSTRACT (22) PCT Filed: Mar. 30, 2011 Provided herein is a library that comprises a plurality of molecular beacons (MBs), each MB having a detectable (86). PCT No.: PCT/US2O11AO3O430 label, a detectable label blocker and a modifier group. The S371 (c)(1), library is used in conjunction with nanopore unzipping-de (2), (4) Date: Apr. 17, 2013 pendent sequencing of nucleic acids. Patent Application Publication Aug. 8, 2013 Sheet 1 of 18 US 2013/020361.0 A1 . N s Patent Application Publication Aug. 8, 2013 Sheet 2 of 18 US 2013/020361.0 A1 I’9IAI ::::::::::: Dº3.modoueN Patent Application Publication Aug. 8, 2013 Sheet 3 of 18 US 2013/020361.0 A1 Z’9IAI ~~~~~~~~~);........ Patent Application Publication Aug. 8, 2013 Sheet 4 of 18 US 2013/020361.0 A1 s :·.{-zzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzzz iii. 9 iii.338 lii &S Patent Application Publication Aug. 8, 2013 Sheet 5 of 18 US 2013/020361.0 A1 s r Patent Application Publication Aug. -
Peptide Analogue of Glycol Nucleic Acid†
Communications to the Editor Bull. Korean Chem. Soc. 2011, Vol. 32, No. 8 2863 DOI 10.5012/bkcs.2011.32.8.2863 γ3PNA: Peptide Analogue of Glycol Nucleic Acid† Taedong Ok, Joohee Lee, and Hee-Seung Lee* Molecular-Level Interface Research Center, Department of Chemistry, KAIST, Daejeon 305-701 *E-mail: [email protected] Received February 7, 2011, Accepted February 9, 2011 Key Words : Peptide nucleic acids, GNA In the research of the chemical etiology of nucleic acid chemical yield were obtained with Mmt for γ3C and γ3G, Boc structure, the studies from Eschenmoser group1 and Nielsen for γ3A, respectively. In addition, the order of reactions at the group2 have demonstrated that the Watson-Crick base pairing initial steps turned out to be important for efficient synthesis. can be supported by various backbone derivatives. Inspired by For example, in case of γ3C, the protection of the amino groups the groundbreaking results, other researchers have devoted should be prior to the substitution reaction, whereas the other their attention to finding artificial nucleic acids that can form route worked better for the purine monomers (γ3A and γ3G). duplexes, in which both synthetic accessibility and new The detailed synthetic procedures are summarized in characteristics for potential therapeutic (or diagnostic) use are Scheme 1. The common intermediate bromide 1 was easily desirable aims.3 In this context, GNA (glycol nucleic acid, prepared from (S)-epichlorohydrin (> 99%ee) in three steps Figure 1A) is a promising artificial nucleic acid because it is (34% overall yield).6,7 For the synthesis of γ3A, the bromide 1 structurally very simple with a high atom economy and was reacted with unprotected adenine base in the presence of forms a duplex by Watson-Crick base pairing.4 sodium hydride in DMF for 48 hr at room temperature. -
And Chemical-Activated Nucleosides and Unnatural Amino Acids. (Under the Direction of Dr
ABSTRACT LIU, QINGYANG. Synthesis of Photo- and Chemical-Activated Nucleosides and Unnatural Amino Acids. (Under the direction of Dr. Alexander Deiters). Synthetic oligonucleotides coupled with photolabile caging groups have been developed to regulate a variety of biological processes in a spatial and temporal fashion. A UV-cleavable caging group was installed on deoxyadenosine and two morpholino oligonucleotide (MO) monomers of which the morpholino core synthesis was also investigated. The synthesis of a two-photon caging group was optimized and two chromophores with > 400 nm absorption maximum were applied to cage thymidine. These caged monomers can serve as light-triggers of oligonucleotide function upon incorporation. Two phosphine-labile azido thymidine derivatives were synthesized as orthogonal small molecule-triggers to the above light-triggers. Additionally, two coumarin linkers were synthesized, which can cyclize a linear MO so as to inactivate MO activity until > 400 nm light irradiation. These two linkers have been applied to the wavelength-selective regulation of zebrafish embryo development. An azide linker was also synthesized to control MOs using phosphines, as well as a UV-cleavable phosphoramidite to regulate DNA oligonucleotide activities. On the regulation of proteins, a two-photon caged lysine, four azido lysines and an azido tyrosine were synthesized to control protein function with either light or small molecules. The phosphine-induced cleavage of the azido groups were investigated on a coumarin reporter. A fluorescent lysine and an isotope labeled lysine were also synthesized as additional biophysical probes to label protein. These unnatural amino acids have been or will be incorporated into proteins through exogenous tRNA-aaRSs pairs. -
Secretariat of the CBD Technical Series No. 82 Convention on Biological Diversity
Secretariat of the CBD Technical Series No. 82 Convention on Biological Diversity 82 SYNTHETIC BIOLOGY FOREWORD To be added by SCBD at a later stage. 1 BACKGROUND 2 In decision X/13, the Conference of the Parties invited Parties, other Governments and relevant 3 organizations to submit information on, inter alia, synthetic biology for consideration by the Subsidiary 4 Body on Scientific, Technical and Technological Advice (SBSTTA), in accordance with the procedures 5 outlined in decision IX/29, while applying the precautionary approach to the field release of synthetic 6 life, cell or genome into the environment. 7 Following the consideration of information on synthetic biology during the sixteenth meeting of the 8 SBSTTA, the Conference of the Parties, in decision XI/11, noting the need to consider the potential 9 positive and negative impacts of components, organisms and products resulting from synthetic biology 10 techniques on the conservation and sustainable use of biodiversity, requested the Executive Secretary 11 to invite the submission of additional relevant information on this matter in a compiled and synthesised 12 manner. The Secretariat was also requested to consider possible gaps and overlaps with the applicable 13 provisions of the Convention, its Protocols and other relevant agreements. A synthesis of this 14 information was thus prepared, peer-reviewed and subsequently considered by the eighteenth meeting 15 of the SBSTTA. The documents were then further revised on the basis of comments from the SBSTTA 16 and peer review process, and submitted for consideration by the twelfth meeting of the Conference of 17 the Parties to the Convention on Biological Diversity. -
UNIVERSITY of CALIFORNIA, IRVINE an Expanded Genetic Code
UNIVERSITY OF CALIFORNIA, IRVINE An expanded genetic code for the characterization and directed evolution of tyrosine-sulfated proteins DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILSOPHY in Biomedical Engineering by Xiang Li Dissertation Committee: Assistant Professor Chang C. Liu, Chair Associate Professor Wendy Liu Associate Professor Jennifer A. Prescher 2018 Portion of Chapter 2 © John Wiley and Sons Portion of Chapter 3 © Springer Portion of Chapter 4 © Royal Society of Chemistry All other materials © 2018 Xiang Li i Dedication To My parents Audrey Bai and Yong Li and My brother Joshua Li ii Table of Content LIST OF FIGURES ..................................................................................................................VI LIST OF TABLES ................................................................................................................. VIII CURRICULUM VITAE ...........................................................................................................IX ACKNOWLEDGEMENTS .................................................................................................... XII ABSTRACT .......................................................................................................................... XIII CHAPTER 1. INTRODUCTION ................................................................................................ 1 1.1. INTRODUCTION ................................................................................................................. -
Expanding the Genetic Code Lei Wang and Peter G
Reviews P. G. Schultz and L. Wang Protein Science Expanding the Genetic Code Lei Wang and Peter G. Schultz* Keywords: amino acids · genetic code · protein chemistry Angewandte Chemie 34 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim DOI: 10.1002/anie.200460627 Angew. Chem. Int. Ed. 2005, 44,34–66 Angewandte Protein Science Chemie Although chemists can synthesize virtually any small organic molecule, our From the Contents ability to rationally manipulate the structures of proteins is quite limited, despite their involvement in virtually every life process. For most proteins, 1. Introduction 35 modifications are largely restricted to substitutions among the common 20 2. Chemical Approaches 35 amino acids. Herein we describe recent advances that make it possible to add new building blocks to the genetic codes of both prokaryotic and 3. In Vitro Biosynthetic eukaryotic organisms. Over 30 novel amino acids have been genetically Approaches to Protein encoded in response to unique triplet and quadruplet codons including Mutagenesis 39 fluorescent, photoreactive, and redox-active amino acids, glycosylated 4. In Vivo Protein amino acids, and amino acids with keto, azido, acetylenic, and heavy-atom- Mutagenesis 43 containing side chains. By removing the limitations imposed by the existing 20 amino acid code, it should be possible to generate proteins and perhaps 5. An Expanded Code 46 entire organisms with new or enhanced properties. 6. Outlook 61 1. Introduction The genetic codes of all known organisms specify the same functional roles to amino acid residues in proteins. Selectivity 20 amino acid building blocks. These building blocks contain a depends on the number and reactivity (dependent on both limited number of functional groups including carboxylic steric and electronic factors) of a particular amino acid side acids and amides, a thiol and thiol ether, alcohols, basic chain. -
Synthetic Life Synthetic Life SL3-4
15.11.2018 Aptamers Synthetic life SL3SL3SL3-SL3 ---4444 Aptamers (from the Latin aptus – fit, and Greek meros – part) are oligonucleotide or peptide molecules that bind to a specific target molecule. Aptamers are usually created by selecting them from a large random sequence pool, but natural aptamers also exist in riboswitches. •DNA or RNA or XNA aptamers – oligonucleotide strands (usually short) •Peptide aptamers - one (or more) short variable peptide domains, attached at both ends to a protein scaffold. Photo credit: Jenny Mottar, NASA NaturalNews.com WiSe 2018/19 Structure of an RNA aptamer specific for biotin. The aptamer surface and backbone Variety of target molecules Zbigniew Pianowski are shown in yellow. Biotin (spheres) fits snugly into a cavity of the RNA surface Fdardel Systematic evolution of ligands by exponential enrichment - SELEX Systematic evolution of ligands by exponential enrichment - SELEX In vitro selection begins with the generation 1990 – Gold et al. – selection of RNA ligands against T4 DNA polymerase of a diverse library of DNA or RNA molecules. 1990 – J. Szostak et al. – selecting RNA ligands towards organic dyes Multiple rounds are performed until The library is then the library converges on to a introduced to a target ligand collection of sequences with affinity for the target molecule. The bound sequences are then collected and PCR amplified for subsequent rounds of enrichment. A general overview of in vitro selection protocol. NA stands for Nucleic Acids (DNA, RNA) which Sequences demonstrating affinity start as a random pool, and are enriched through the selection process towards the target molecule are isolated from any unbound sequences. -
Biomolecule, Pathway, and Circuit Engineering (Biomolecular Engineering)
June 2019 Biomolecule, Pathway, and Circuit Engineering (Biomolecular Engineering) Engineering Biology: A Research Roadmap for the Next-Generation Bioeconomy 27 5885 Hollis Street, 4th Floor, Emeryville, CA 94608 Phone: +1.510.871.3272 Fax: +1.510.245.2223 This material is based upon work supported by the National Science Foundation under Grant No. 1818248. © 2019 Engineering Biology Research Consortium June 2019 Biomolecule, Pathway, and Circuit Engineering Summary Biomolecule, Pathway, and Circuit Engineering focuses on the importance, challenges, and goals of engineering individual biomolecules themselves to have expanded or new functions. Successful progress would be demonstrated by production of functional macromolecules on- demand from both natural and non-natural building blocks, targeted design of complex circuits and pathways, and control over the dynamics of regulatory systems. Introduction and Impact At the molecular level, the functional richness, complexity, and diversity of biology can be localized predominantly to large “macro”-molecules (nucleic acids and proteins) and secondary metabolites. Indeed, evolution has produced and leveraged biomolecules and their assemblies to achieve extraordinarily sophisticated natural functions far surpassing our current engineering capabilities. If researchers are able to efficiently design, generate, synthesize, assemble, and regulate biomolecules in ways that rival the functional complexity of natural counterparts, but with user-defined functions, then all areas of bioengineering and synthetic biology should benefit. The challenge of crafting biomolecules, pathways, and circuits that carry out user-defined functions has historically been an exercise in building out from what exists in nature to what doesn’t. Certainly, this mode of bioengineering will be important going forward and will see transformations as our knowledge of and ability to harvest what exists in nature increases. -
A Thermostable D-Polymerase for Mirror-Image
Published online 2 February 2017 Nucleic Acids Research, 2017, Vol. 45, No. 7 3997–4005 doi: 10.1093/nar/gkx079 A thermostable D-polymerase for mirror-image PCR Andreas Pech1,†, John Achenbach2,†, Michael Jahnz2, Simone Schulzchen¨ 1, Florian Jarosch2, Frank Bordusa3 and Sven Klussmann2,* 1NOXXON Pharma AG, Weinbergweg 23, 06120 Halle (Saale), Germany, 2NOXXON Pharma AG, Max-Dohrn-Str. 8–10, 10589 Berlin, Germany and 3Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Strasse 3, 06120 Halle (Saale), Germany Received December 02, 2016; Revised January 19, 2017; Editorial Decision January 25, 2017; Accepted January 27, 2017 ABSTRACT ing to mirror-image L-adenosine and its corresponding L- RNA aptamer (so-called Spiegelmer®) comparably recog- Biological evolution resulted in a homochiral world nizing D-adenosine (4). Since compounds made of mirror- in which nucleic acids consist exclusively of D- image building blocks show high biostability and low im- nucleotides and proteins made by ribosomal trans- munogenicity, L-nucleic acid aptamers and D-peptides are lation of L-amino acids. From the perspective of now being developed as therapeutic modalities (5,6). synthetic biology, however, particularly anabolic en- The dream of creating a living cell in the lab de novo has zymes that could build the mirror-image counterparts been around for some time (7,8) and significant progress of biological macromolecules such as L-DNA or L- such as the synthesis of a whole genome now controlling RNA are lacking. Based on a convergent synthesis viable cells (9) has been achieved. Also, the vision of mirror strategy, we have chemically produced and charac- life as an object of investigation, e.g. -
"Synthesis of Glycerol Nucleic Acid (GNA) Phosphoramidite
Synthesis of Glycerol Nucleic Acid (GNA) UNIT 4.40 Phosphoramidite Monomers and Oligonucleotide Polymers Su Zhang1,2 and John C. Chaput1,2 1Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 2The Biodesign Institute at Arizona State University, Tempe, Arizona ABSTRACT This unit describes a straightforward method for preparing glycerol nucleic acid (GNA) phosphoramidite monomers and oligonucleotide polymers using standard cyanoethyl phosphoramidite chemistry. GNA is an unnatural nucleic acid analog composed of an acyclic three-carbon sugar-phosphate backbone that contains one stereogenic center per repeating unit. GNA has attracted significant attention as a nucleic acid derivative due to its unique ability to form stable Watson-Crick anti-parallel duplex structures with thermal and thermodynamic stabilities rivaling those of natural DNA and RNA. The chemical simplicity of this nucleic acid structure provides access to enantiomerically pure forms of right- and left-handed helical structures that can be used as unnatural building blocks in DNA nanotechnology. Curr. Protoc. Nucleic Acid Chem. 42:4.40.1-4.40.18. C 2010 by John Wiley & Sons, Inc. Keywords: glycerol nucleic acid (GNA) r phosphoramidite r oligonucleotide r chemical synthesis r solid-phase synthesis r thermal stability r nanotechnology INTRODUCTION Acyclic oligonucleotides are experiencing a tremendous resurgence in basic and applied research due to their unique structural and biophysical properties (for a review, see Zhang et al., 2010). This unit contains procedures that describe the chemical synthesis of one type of acyclic nucleic acid polymer commonly referred to as glycerol nucleic acid or GNA. The chemical synthesis and purification of glycerol nucleoside analogs bearing adenine (A), cytosine (C), guanine (G), and thymine (T) as the bases, and of oligonucleotides thereof (Fig. -
21St Century Borders/Synthetic Biology: Focus on Responsibility and Governance
Social science Engineering Framework Institute on Science for Global Policy (ISGP) Risk-benefit Media Public Synthetic Biology Genetic Governance Regulation Voluntary Anticipatory Databases Xenobiology 21st Century Borders/Synthetic Biology: Focus on Responsibility and Governance Conference convened by the ISGP Dec. 4–7, 2012 at the Hilton El Conquistador, Tucson, Arizona Risk Technology Oversight Plants Uncertainty Product Less-affluent countries DIYBIO Biotechnology Emerging Dynamic Environmental Government Biosafety Self-regulation Nefarious Genetically modified Protein Standards Dual use Distribution Applications Food Microbial Authority Assessment Agricultural Institute on Science for Global Policy (ISGP) 21st Century Borders/Synthetic Biology: Focus on Responsibility and Governance Conference convened by the ISGP in partnership with the University of Arizona at the Hilton El Conquistador Hotel Tucson, Arizona, U.S. Dec. 4–7, 2012 An ongoing series of dialogues and critical debates examining the role of science and technology in advancing effective domestic and international policy decisions Institute on Science for Global Policy (ISGP) Tucson, AZ Office 845 N. Park Ave., 5th Floor PO Box 210158-B Tucson, AZ 85721 Washington, DC Office 818 Connecticut Ave. NW Suite 800 Washington, DC 20006 www.scienceforglobalpolicy.org © Copyright Institute on Science for Global Policy, 2013. All rights reserved. ISBN: 978-0-9803882-4-0 ii Table of contents Executive summary • Introduction: Institute on Science for Global Policy (ISGP) .............. 1 Dr. George H. Atkinson, Founder and Executive Director, ISGP, and Professor Emeritus, University of Arizona • Conference conclusions: Areas of consensus and Actionable next steps ...................................... 7 Conference program ........................................................................................... 11 Policy position papers and debate summaries • Synthetic Biology — Do We Need New Regulatory Systems? Prof.